[SRNE] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
11-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -20.55%
YoY- -101.98%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 17,400 11,461 18,385 13,076 12,062 13,511 14,255 14.20%
PBT -91,702 -220,599 -38,946 -178,068 -119,773 -167,340 2,212 -
Tax -1,015 -1,050 1,463 -33,055 386 -641 -206 189.27%
NP -90,687 -219,549 -40,815 -144,417 -119,803 -166,615 2,510 -
Tax Rate - - - - - - 9.31% -
Total Cost 108,087 231,010 59,200 157,493 131,865 180,126 11,745 338.55%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -521.19 -1,915.62 -222.00 -1,104.44 -993.23 -1,233.18 17.61 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.20 -0.55 -0.12 -0.47 -0.40 -0.57 0.01 -
EPS Diluted -0.20 -0.55 -0.12 -0.47 -0.40 -0.57 0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.